High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
about
High dose chemotherapy with stem cell support in the treatment of testicular cancerIntensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.High-dose chemotherapy for germ cell tumors: do we have a model?Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.Current Management of Refractory Germ Cell Tumors and Future Directions.Platinum-refractory germ cell tumors: an update on current treatment options and developments.High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases.[Update on first-line and relapse chemotherapy for testicular cancer].Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion.Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upA phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
P2860
Q26771162-07EB5ED5-3ED1-4E4F-8362-2A5265658690Q34886445-27821F95-6657-49B7-9528-78FB8451E4BBQ37905875-0281545B-9A68-4C3D-B838-5BFCA4732B12Q38253101-57E33E74-310E-4198-AD4F-DE16A5F21C7DQ38666300-A79E6B8D-D934-41CA-AD81-8934913EC1D3Q38755132-7A81E171-C64D-45E6-A4B4-A698C858CCDFQ38906007-F3A79ABA-D36F-4651-8826-9575445D4997Q38966419-83B0D3AE-8FF2-49A6-A699-2D4F21EDF367Q43223621-9C8F3AE6-1C79-4F95-BB41-C0FDFAEAF0C3Q46946815-54878FA3-E20F-44FA-8ADF-5C4AF54396F7Q48150809-7B87A4F1-2AF5-456A-B1AA-103B837B7E34Q54760631-D9274D7F-6D8F-473F-A415-84B0F767C453Q55050439-FB0A3D98-7EC8-43D7-A812-D1DC7404BC23Q55332886-D98C16A7-EE9E-427F-9901-A83424531D8BQ57278891-32DDE8F3-7898-42CD-AFCE-EA51D2BFBC7CQ57579466-DEB2457D-76CD-4B2C-B209-EDA797B47AD8
P2860
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
High-dose chemotherapy (HDCT) ...... r refractory germ-cell tumors.
@en
High-dose chemotherapy
@nl
type
label
High-dose chemotherapy (HDCT) ...... r refractory germ-cell tumors.
@en
High-dose chemotherapy
@nl
prefLabel
High-dose chemotherapy (HDCT) ...... r refractory germ-cell tumors.
@en
High-dose chemotherapy
@nl
P2093
P2860
P356
P1433
P1476
High-dose chemotherapy (HDCT) ...... r refractory germ-cell tumors.
@en
P2093
A Neubauer
C Bokemeyer
J T Hartmann
M Hackenthal
P2860
P304
P356
10.1093/ANNONC/MDP366
P577
2009-10-11T00:00:00Z